ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Defiance Daily Target 2X Long RKLB ETF

Defiance Daily Target 2X Long RKLB ETF (RKLX)

63,45
-10,38
(-14,06%)
Fermé 04 Juin 10:00PM
60,05
-3,40
(-5,36%)
Après les heures de négociation: 1:59AM

Defiance Daily Target 2X Long RKLB ETF ([symbol]) Options

Achats

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
50,0016,2019,5018,2417,85-31,69-63,47 %14603/6/2026
51,0015,4018,9048,6517,150,000,00 %00-
52,0014,8018,3053,2116,550,000,00 %011-
53,0014,2017,7014,0015,950,000,00 %01-
54,0013,6017,0016,2015,300,000,00 %02-
55,0013,4016,5028,0614,950,000,00 %011-
56,0013,3015,7021,8814,500,000,00 %04-
57,0012,6015,4046,1014,000,000,00 %02-
58,0012,1014,7031,5013,400,000,00 %010-
59,0011,6014,3022,0012,950,000,00 %02-
60,0011,2013,9012,7012,55-7,15-36,02 %12503/6/2026
61,0010,8013,4034,0012,100,000,00 %02-
62,0010,2012,9048,7811,550,000,00 %08-
63,009,8012,7023,9111,250,000,00 %02-
64,009,4012,0010,5010,70-30,90-74,64 %1103/6/2026
65,009,1011,9010,0010,50-8,36-45,53 %78403/6/2026
66,008,7011,008,989,85-11,52-56,20 %122903/6/2026
67,008,4011,0040,709,700,000,00 %00-
68,007,9010,8012,509,350,000,00 %6003/6/2026
69,007,5010,5011,969,00-6,24-34,29 %1903/6/2026

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Ventes

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
50,002,855,004,303,9251,3847,26 %5043403/6/2026
51,003,105,404,444,252,94196,00 %34103/6/2026
52,003,605,703,594,650,5919,67 %1603/6/2026
53,004,006,804,505,400,000,00 %015-
54,004,406,702,955,550,000,00 %02-
55,004,807,006,505,902,1549,43 %47903/6/2026
56,005,308,507,006,903,0075,00 %31903/6/2026
57,005,808,505,007,150,000,00 %09-
58,006,408,907,007,652,1042,86 %1603/6/2026
59,006,909,408,058,151,5523,85 %16103/6/2026
60,007,809,008,908,402,8045,90 %1814303/6/2026
61,007,9010,505,509,200,000,00 %010-
62,008,5011,009,659,752,6337,46 %2903/6/2026
63,009,0011,908,0010,450,000,00 %07-
64,009,6012,207,7510,900,000,00 %09-
65,0011,0012,6011,0611,802,6631,67 %211103/6/2026
66,0010,8013,7010,5012,252,7034,62 %1803/6/2026
67,0011,6014,008,9012,800,000,00 %045-
68,0012,2014,6013,3013,403,7539,27 %22903/6/2026
69,0013,0015,2014,1014,104,1041,00 %2903/6/2026

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
XOSXos Inc
US$ 7,47
(234,98%)
107,64M
WCTWellchange Holdings Company Ltd
US$ 2,565
(178,80%)
85,22M
SDOTSadot Group Inc
US$ 6,79
(107,01%)
52,56M
STAKSTAK Inc
US$ 3,59
(88,95%)
27,19M
SELXSemilux International Ltd
US$ 0,464101
(63,42%)
181,71M
NOTVInotiv Inc
US$ 0,1173
(-54,88%)
22,77M
RPGLRepublic Power Group Ltd
US$ 5,85
(-48,05%)
1,58M
JZJianzhi Education Technology Group Company Ltd
US$ 0,3832
(-45,26%)
14,59M
CETXCemtrex Inc
US$ 0,592949
(-36,31%)
2,08M
SNGXSoligenix Inc
US$ 0,4999
(-33,24%)
6,77M
HUBCHub Cyber Security Ltd
US$ 0,6275
(30,73%)
287,58M
ZCMDZhongchao Inc
US$ 0,0535
(-2,37%)
269,67M
LASELaser Photonics Corporation
US$ 3,1299
(29,33%)
228,9M
SELXSemilux International Ltd
US$ 0,464101
(63,42%)
181,71M
WOKWORK Medical Technology Group Ltd
US$ 0,1075
(3,37%)
181,27M
dinogreeves dinogreeves il y a 5 minutes
Now that the Delfin Midstream Final Investment Decision (FID) is officially complete, the project is expected to trade publicly by utilizing theglobe.com, inc. (TGLO) as its public vehicle through a structured reverse merger.Because Delfin has meticulously maintained and funded this SEC-reporting pu
TGLO
sentiment_stocks sentiment_stocks il y a 9 minutes
Yes, but that Stupp result would have included a decent number of IDH mutated patients who live longer and are no longer considered GBM. The question now is, what is the mOS for IDH wild type GBM patients only?
NWBO
Slojab Slojab il y a 9 minutes
MM signals. Lord help us. 🥱
QEDN
dinogreeves dinogreeves il y a 10 minutes
Yes, the addition of Global Infrastructure Partners (GIP), a powerhouse asset manager backed by BlackRock, fundamentally changes the outlook for Delfin Midstream and by extension, TGLO.This partnership transitions the project from a highly speculative penny-stock narrative into a heavily institution
TGLO
nowwhat2 nowwhat2 il y a 11 minutes
Boy, that was really sumpthin' huh ?


https://investorshub.advfn.com/uimage/uploads/2026/6/3/gkubkbtc_june_3_5d_1215_OHTL66666__PENCIL_BELL.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/3/bocvjbtc_june_3_5d_7pm_pencil.jpg


BTCUSD
Biotrader23 Biotrader23 il y a 13 minutes
spoke today with Alex Arzeno of SCR Partners whom Terrie K (or jing ma) hired for IR.. dude seems to have decent background in real estate biz namely REITs but complete nube in biotech/healthcare.. they never served any publicly traded biotechs so cant really blame them, they wouldnt say no to new c
AVXL
norisknorewards norisknorewards il y a 13 minutes
Maybe nwbo displayed (the misunderstood) pfs endpoint first (before the OS result), on purpose, on that Mulholland slide deck on that fateful day.

I think, in my opinion, dilution is the last thing LP is worried about, because maybe, maybe, she actually did foresee how this would play
NWBO
lakers17 lakers17 il y a 14 minutes
Many reasons. Human nature, lack of money, jealousy of others having more success than they do and many more reasons. Like I always say, trust the process. It's clear what is being developed in the US. Clarity is important but so is getting crypto in the Federal Reserve. That's just the US. 21
BTCUSD
Investor082 Investor082 il y a 15 minutes
There were a lot of dreamers like you pre TLD and JAMA expecting $20+ share price in 2022 and had already made plans on spending it. Make sure LP and her financiers don’t take you for a ride while you’re en-route to the beach. That scream could end up being in anguish, LOL! ;)
NWBO
Gravedigger1 Gravedigger1 il y a 15 minutes
Morality?I’m judging your use of time - entirely your choice and on full display - while you have a claim to incredible experience, insight, knowledge, foresight(!!!), and pity the rest of the investment world.
Newsflash:Some people make money and don’t need to “guard” a stock daily.
T
AVXL
axelvento axelvento il y a 17 minutes
New cancer vaccine delivers stunning result against one of the deadliest skin cancers

KEYNOTE-942
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

According to
MRNA
TexasMarvL TexasMarvL il y a 17 minutes
CEO Kimberly Ann. 
She definitely has a lot of confidence.   I want to hang on just to she if she can deliver.

https://youtu.be/htDcyIyYums?si=7RxZ3lRhGaQu-PQE


LGCXF
chen1992 chen1992 il y a 18 minutes
The fact that we aren’t talking about FID anymore and now all eyes are on the 8-K is surreal. It feel dream like after so many letdowns
TGLO
douginil douginil il y a 21 minutes
Hmmmm

I wonder if our process into metals and oxides gets us into 5 nine purity.
NB
Investor2014 Investor2014 il y a 22 minutes
Ah, OhSay’s older and wiser brother finally arrives, very late in the Anavex saga and, unlike his younger brother, having actually made money from his $AVXL insights. That apparently now qualifies you to lecture others on morality and judge message-board posters with unwavering conviction.
AVXL
Investors3 Investors3 il y a 22 minutes
I agree with you. If BTC was a good investment at a higher price, then why not buy more, when it is down? I actually find my crypto investments much more exciting than my stock investments. And being able to buy when i want (24 x7) is also a nice benefit. Yes, i don't understand why some people cele
BTCUSD
georgejjl georgejjl il y a 23 minutes
New Treatment for Alzheimer’s and Parkinson’s Discovered in JapanResearchers use a vitamin K and vitamin A hybrid to transform stem cells into functional neurons, offering a potential path to restoring lost brain function.

https://www.inc.com/lucia-auerbach/future-of-brain-health-how-
AVXL
ZenChimera371 ZenChimera371 il y a 23 minutes
So, a couple things here.

1. There seems to be inconsistency in the filing regarding communication about convertible debt reduction. They claimed 1 million reduction but I am not seeing that reduction noted in the actual filings for that time period.

2. How are they avo
BLEGD
Biotrader23 Biotrader23 il y a 24 minutes
call it BS since they signed off on the CSR
AVXL
SemperFITrader SemperFITrader il y a 25 minutes
FMc, Both CTBVEAG and CHM are under Licensing, how many times do I have to say that, nothing else really has to be stated past that. CTA data is meaningless since it relates to Clinical Trial Acceptance. Marketing Authorisation under Licenses is the key to both meetings period.
I asked you
NWBO
Split T Split T il y a 26 minutes
Wow, LIBOR and Ezell litigation ends and some of you think that the price is dropping because sellers are pulling listings..lol. you might ought to rethink why the shorts are buying hand over fist.
RKT
Biotrader23 Biotrader23 il y a 29 minutes
Been holding sig AVXL position for the last 5 years, regulatory setbacks are common in biotech world, some of my best winners had to overcome those..

Since we have no cash/runway issues my biggest worry at the moment is the direction: Jing Ma (aka SPAC queen) firmly in charge, just lo
AVXL
Nightdaytrader Nightdaytrader il y a 30 minutes
There are so many mistakes and falsehoods in this AI Project West post. Too many to comment on..

There is also this AI statement which is totally wrong. AI stated: "Releasing JPM and others from potential claims (including willful misconduct carve-outs or negotiations around them)
RKT
GreenShoots GreenShoots il y a 35 minutes
Everybody sees what you refuse to. Don’t be mad cuz you down and out. Don’t hate people that have been here for so long and NOW see the TRUTH. You wanna go down with the ship, do it. Just don’t hate people that see what is happening
FNMA
skitahoe skitahoe il y a 36 minutes
I believe it the Will Rodger's simple stock advice, Buy Good Stock.
The fact that it's been down much of the time I've been in it leads to his principle that if it's up, good, if it's down, better, buy more.

If the stock had moved up from the time I first bought it, I doubt i
NWBO